{"id":4787,"date":"2026-03-20T15:41:10","date_gmt":"2026-03-20T14:41:10","guid":{"rendered":"https:\/\/ph-vzw.be\/?p=4787"},"modified":"2026-06-10T14:36:37","modified_gmt":"2026-06-10T12:36:37","slug":"resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap","status":"publish","type":"post","link":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/","title":{"rendered":"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP"},"content":{"rendered":"<p>[vc_row gap=\u00a0\u00bb35&Prime;][vc_column width=\u00a0\u00bb1\/3&Prime;][vc_single_image image=\u00a0\u00bb4341&Prime; img_size=\u00a0\u00bblarge\u00a0\u00bb add_caption=\u00a0\u00bbyes\u00a0\u00bb][\/vc_column][vc_column width=\u00a0\u00bb2\/3&Prime;][vc_column_text]<\/p>\n<h2>\u00c9tude PROSERA : r\u00e9sultats mitig\u00e9s, mais des signaux positifs importants pour le s\u00e9ralutinib dans l\u2019HTAP<\/h2>\n<p>Gossamer Bio a publi\u00e9 les r\u00e9sultats de l\u2019\u00e9tude PROSERA portant sur le s\u00e9ralutinib pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire (HTAP).<br \/>\nLe crit\u00e8re principal d\u2019\u00e9valuation n\u2019a pas \u00e9t\u00e9 enti\u00e8rement atteint dans la population totale de l\u2019\u00e9tude \u2014 probablement en raison d\u2019effets placebo inattendus dans certaines r\u00e9gions. Malgr\u00e9 cela, les donn\u00e9es montrent des r\u00e9sultats importants et encourageants dans plusieurs sous\u2011groupes de patients.<\/p>\n<h3>Principales conclusions<\/h3>\n<ul>\n<li>Les patients atteints d\u2019HTAP \u00e0 risque interm\u00e9diaire ou \u00e9lev\u00e9 (le groupe au pronostic le plus d\u00e9favorable) ont pr\u00e9sent\u00e9 des b\u00e9n\u00e9fices coh\u00e9rents. Ces r\u00e9sultats sont en ligne avec ceux de l\u2019\u00e9tude de phase 2 TORREY, indiquant un profil d\u2019efficacit\u00e9 stable dans cette population vuln\u00e9rable.<\/li>\n<li>\u00a0Les patients souffrant d\u2019HTAP li\u00e9e \u00e0 une maladie du tissu conjonctif ont montr\u00e9 une am\u00e9lioration significative de la distance de marche, soulignant le potentiel du s\u00e9ralutinib dans ce sous\u2011groupe difficile \u00e0 traiter. Dans la population globale, on observe une baisse nette des taux de NT\u2011proBNP d\u00e8s la semaine 4, ainsi que des tendances favorables pour tous les crit\u00e8res secondaires, y compris le d\u00e9lai jusqu\u2019\u00e0 l\u2019aggravation clinique.<\/li>\n<li>L\u2019extension en ouvert de l\u2019\u00e9tude se poursuit et continue de montrer des r\u00e9sultats positifs.<\/li>\n<\/ul>\n<h3>Important pour les patients<\/h3>\n<div>Les patients d\u00e9j\u00e0 trait\u00e9s par s\u00e9ralutinib dans le cadre de l\u2019\u00e9tude peuvent poursuivre leur traitement. Le programme n\u2019est donc pas interrompu.<\/div>\n<div><\/div>\n<div>\n<h3>Prochaines \u00e9tapes<\/h3>\n<\/div>\n<div>Gossamer Bio pr\u00e9voit prochainement des discussions avec la <a href=\"https:\/\/www.fda.gov\/\"><b>FDA<\/b>\u00a0<\/a>afin d\u2019examiner les \u00e9tapes suivantes du d\u00e9veloppement du s\u00e9ralutinib.<\/div>\n<div><\/div>\n<p>Vous pouvez lire<strong> le communiqu\u00e9 de presse complet\u00a0<\/strong>de<a href=\"https:\/\/ir.gossamerbio.com\/news-releases\/news-release-details\/gossamer-bio-announces-topline-results-phase-3-prosera-study\"> Gossamer Bio v<\/a>ia le lien disponible sur leur site web.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP<\/p>\n","protected":false},"author":12,"featured_media":4341,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[10],"tags":[82],"class_list":["post-4787","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee","tag-centres"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP - Pulmonale hypertentie vzw<\/title>\n<meta name=\"description\" content=\"\u00c9tude PROSERA : r\u00e9sultats mitig\u00e9s, mais des signaux positifs importants pour le s\u00e9ralutinib dans l\u2019HTAPGossamer Bio\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP - Pulmonale hypertentie vzw\" \/>\n<meta property=\"og:description\" content=\"\u00c9tude PROSERA : r\u00e9sultats mitig\u00e9s, mais des signaux positifs importants pour le s\u00e9ralutinib dans l\u2019HTAPGossamer Bio\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/\" \/>\n<meta property=\"og:site_name\" content=\"Pulmonale hypertentie vzw\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-20T14:41:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-10T12:36:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ph-vzw.be\/wp-content\/uploads\/2026\/03\/studie.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"851\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Els Schevenels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Els Schevenels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/\"},\"author\":{\"name\":\"Els Schevenels\",\"@id\":\"https:\/\/ph-vzw.be\/fr\/#\/schema\/person\/9784077930491308e7d10be832b89e30\"},\"headline\":\"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP\",\"datePublished\":\"2026-03-20T14:41:10+00:00\",\"dateModified\":\"2026-06-10T12:36:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/\"},\"wordCount\":354,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ph-vzw.be\/fr\/#organization\"},\"keywords\":[\"Centres\"],\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/\",\"url\":\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/\",\"name\":\"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP - Pulmonale hypertentie vzw\",\"isPartOf\":{\"@id\":\"https:\/\/ph-vzw.be\/fr\/#website\"},\"datePublished\":\"2026-03-20T14:41:10+00:00\",\"dateModified\":\"2026-06-10T12:36:37+00:00\",\"description\":\"\u00c9tude PROSERA : r\u00e9sultats mitig\u00e9s, mais des signaux positifs importants pour le s\u00e9ralutinib dans l\u2019HTAPGossamer Bio\",\"breadcrumb\":{\"@id\":\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ph-vzw.be\/fr\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ph-vzw.be\/fr\/#website\",\"url\":\"https:\/\/ph-vzw.be\/fr\/\",\"name\":\"Pulmonale hypertentie vzw\",\"description\":\"Samen op adem komen\",\"publisher\":{\"@id\":\"https:\/\/ph-vzw.be\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ph-vzw.be\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ph-vzw.be\/fr\/#organization\",\"name\":\"Pulmonale hypertentie vzw\",\"url\":\"https:\/\/ph-vzw.be\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ph-vzw.be\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ph-vzw.be\/wp-content\/uploads\/2022\/09\/Pulmonale_hypertentie.png\",\"contentUrl\":\"https:\/\/ph-vzw.be\/wp-content\/uploads\/2022\/09\/Pulmonale_hypertentie.png\",\"width\":1243,\"height\":391,\"caption\":\"Pulmonale hypertentie vzw\"},\"image\":{\"@id\":\"https:\/\/ph-vzw.be\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ph-vzw.be\/fr\/#\/schema\/person\/9784077930491308e7d10be832b89e30\",\"name\":\"Els Schevenels\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ph-vzw.be\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0a03debf977fac25f984f2c6f5e576cb65514126231f199fe913b2be78eeaa24?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0a03debf977fac25f984f2c6f5e576cb65514126231f199fe913b2be78eeaa24?s=96&d=mm&r=g\",\"caption\":\"Els Schevenels\"},\"url\":\"https:\/\/ph-vzw.be\/fr\/author\/els\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP - Pulmonale hypertentie vzw","description":"\u00c9tude PROSERA : r\u00e9sultats mitig\u00e9s, mais des signaux positifs importants pour le s\u00e9ralutinib dans l\u2019HTAPGossamer Bio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP - Pulmonale hypertentie vzw","og_description":"\u00c9tude PROSERA : r\u00e9sultats mitig\u00e9s, mais des signaux positifs importants pour le s\u00e9ralutinib dans l\u2019HTAPGossamer Bio","og_url":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/","og_site_name":"Pulmonale hypertentie vzw","article_published_time":"2026-03-20T14:41:10+00:00","article_modified_time":"2026-06-10T12:36:37+00:00","og_image":[{"width":1280,"height":851,"url":"https:\/\/ph-vzw.be\/wp-content\/uploads\/2026\/03\/studie.png","type":"image\/png"}],"author":"Els Schevenels","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Els Schevenels","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/#article","isPartOf":{"@id":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/"},"author":{"name":"Els Schevenels","@id":"https:\/\/ph-vzw.be\/fr\/#\/schema\/person\/9784077930491308e7d10be832b89e30"},"headline":"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP","datePublished":"2026-03-20T14:41:10+00:00","dateModified":"2026-06-10T12:36:37+00:00","mainEntityOfPage":{"@id":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/"},"wordCount":354,"commentCount":0,"publisher":{"@id":"https:\/\/ph-vzw.be\/fr\/#organization"},"keywords":["Centres"],"articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/","url":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/","name":"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP - Pulmonale hypertentie vzw","isPartOf":{"@id":"https:\/\/ph-vzw.be\/fr\/#website"},"datePublished":"2026-03-20T14:41:10+00:00","dateModified":"2026-06-10T12:36:37+00:00","description":"\u00c9tude PROSERA : r\u00e9sultats mitig\u00e9s, mais des signaux positifs importants pour le s\u00e9ralutinib dans l\u2019HTAPGossamer Bio","breadcrumb":{"@id":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ph-vzw.be\/fr\/2026\/03\/20\/resultats-de-letude-prosera-sur-le-seralutinib-dans-lhtap\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ph-vzw.be\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"R\u00e9sultats de l\u2019\u00e9tude PROSERA sur le s\u00e9ralutinib dans l\u2019HTAP"}]},{"@type":"WebSite","@id":"https:\/\/ph-vzw.be\/fr\/#website","url":"https:\/\/ph-vzw.be\/fr\/","name":"Pulmonale hypertentie vzw","description":"Samen op adem komen","publisher":{"@id":"https:\/\/ph-vzw.be\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ph-vzw.be\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ph-vzw.be\/fr\/#organization","name":"Pulmonale hypertentie vzw","url":"https:\/\/ph-vzw.be\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ph-vzw.be\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ph-vzw.be\/wp-content\/uploads\/2022\/09\/Pulmonale_hypertentie.png","contentUrl":"https:\/\/ph-vzw.be\/wp-content\/uploads\/2022\/09\/Pulmonale_hypertentie.png","width":1243,"height":391,"caption":"Pulmonale hypertentie vzw"},"image":{"@id":"https:\/\/ph-vzw.be\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ph-vzw.be\/fr\/#\/schema\/person\/9784077930491308e7d10be832b89e30","name":"Els Schevenels","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ph-vzw.be\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0a03debf977fac25f984f2c6f5e576cb65514126231f199fe913b2be78eeaa24?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0a03debf977fac25f984f2c6f5e576cb65514126231f199fe913b2be78eeaa24?s=96&d=mm&r=g","caption":"Els Schevenels"},"url":"https:\/\/ph-vzw.be\/fr\/author\/els\/"}]}},"_links":{"self":[{"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/posts\/4787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/comments?post=4787"}],"version-history":[{"count":6,"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/posts\/4787\/revisions"}],"predecessor-version":[{"id":4832,"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/posts\/4787\/revisions\/4832"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/media\/4341"}],"wp:attachment":[{"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/media?parent=4787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/categories?post=4787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ph-vzw.be\/fr\/wp-json\/wp\/v2\/tags?post=4787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}